[QNRX]

Founded in 2018, Quoin is an emerging specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are… [Read More]

[MIRA]

Mira Pharmaceuticals Developing the next-generation FDA-approved novel synthetic THC analog MIRA1a is being developed to treat anxiety and cognitive decline in the elderly and neuropathic… [Read More]

1-800-Flowers [FLWS]

1-800-FLOWERS.COM, Inc., together with its subsidiaries, provides gifts for various occasions in the United States. It operates in three segments: Consumer Floral; Gourmet Foods &… [Read More]

180 Life Sciences Corp. [ATNF]

180 Life Sciences Corp. (NASDAQ: ATNF) is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases,… [Read More]

Abeona Therapeutics Inc. [ABEO]

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing gene and cell therapies for serious diseases. Abeona’s clinical programs include EB-101, its autologous, gene-corrected cell… [Read More]

ABVC BioPharma, Inc. [ABVC]

ABVC BioPharma (NASDAQ:ABVC), a biopharma and medical device company developing therapies for a range of conditions focused on oncology/hematology, central nervous system (CNS) and ophthalmology,… [Read More]

AC Immune SA [ACIU]

AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease,… [Read More]

Accuray Incorporated [ARAY]

Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle… [Read More]

Achilles Therapeutics plc [ACHL]

Achilles Therapeutics’ mission is to develop next-generation, patient-specific therapies that harness the immune system to destroy cancer cells. The therapies will target truncal (also known… [Read More]